For the second quarter of the fiscal year ending March 2027, consolidated results exceeded 56,082 million yen in net sales, with operating income, ordinary income, and net income attributable to owners of parent increasing year-over-year. Segments including Healthcare and Functional Chemicals performed solidly, and there was no revision to the full-year forecast. An earnings presentation was held, and the full-year dividend forecast including the interim dividend at the end of the second quarter was maintained.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4046","jir_company_name":"Osaka Soda Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4046-20261110-02.pdf","jir_short_summary":"For the second quarter of the fiscal year ending March 2027, consolidated results exceeded 56,082 million yen in net sales, with operating income, ordinary income, and net income attributable to owners of parent increasing year-over-year. Segments including Healthcare and Functional Chemicals performed solidly, and there was no revision to the full-year forecast. An earnings presentation was held, and the full-year dividend forecast including the interim dividend at the end of the second quarter was maintained.","jir_summary":"### Summary of Performance\nUnder the mid-term plan \"Transform Our Future 2030,\" Osaka Soda Co., Ltd. has been restructuring the value of existing businesses and promoting growth in the healthcare domain. By segment, Basic Chemicals, Functional Chemicals, and Healthcare each increased sales driven by demand expansion and price revisions. Company-wide, production efficiency and cost-reduction investments were strengthened, resulting in net sales of 56,082 million yen, operating income of 10,836 million yen, and interim net income of 8,016 million yen, marking record-high levels.\n\n### Outlook and Capital Policy\nThere is no change to the full-year forecast; there was also no revision to the dividend forecast. Treasury stock acquisitions were made during the interim period, increasing treasury stock at fiscal year-end. Improvements in ESG scores led to selection as a constituent of the FTSE JPX Blossom Japan Index, and the company is promoting the use of renewable energy and sustainability management. The company will continue capacity enhancement at new plants and expand sales in China and India.","jir_financial_highlights":"Net Sales: 56,082 (Year-over-Year (YoY) 14.8% increase)\nOperating Income: 10,836 (Year-over-Year (YoY) 33.6% increase)\nOrdinary Income: 11,572 (Year-over-Year (YoY) 29.9% increase)\nNet Income Attributable to Owners of Parent: 8,016 (Year-over-Year (YoY) 18.7% increase)\nEquity Ratio: 75.1 (Decrease of 1.1pt from previous fiscal year)","jir_category":"","jir_hashtags":"#OsakaSoda, #FinancialResults, #InterimResults","jir_key_figures":"Net Sales: 56,082 million yen\nOperating Income: 10,836 million yen\nNet Income Attributable to Owners of Parent: 8,016 million yen","jir_meta_title":"Osaka Soda Co., Ltd. Second Quarter Results | Net Sales 56,082 million yen \u00b7 Operating Income 10,836 million yen","jir_meta_description":"Key points of Osaka Soda Co., Ltd.'s second quarter results for the fiscal year ending March 2027: net sales 56,082 million yen, operating income 10,836 million yen, net income 8,016 million yen. Explanation of segment performance, outlook, dividend policy, and ESG initiatives.","jir_og_title":"Key Points of Osaka Soda Co., Ltd. Second Quarter Results | Net Sales 56,082 million yen and Strong Earnings","jir_og_description":"Osaka Soda Co., Ltd.'s second quarter results showed year-over-year revenue and profit growth, reaching record highs. Details on segment drivers, future strategy, dividend policy, and ESG initiatives are provided.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8704,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-147758","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n